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Abstract. Accurate information regarding malaria prevalence at national level is required to design and assess
malaria control/elimination efforts. Although many comparisons of microscopy and polymerase chain reaction (PCR)–
based methods have been conducted, there is little published literature covering such comparisons in southeast Asia
especially at the national level. Both microscopic examination and PCR detection were performed on blood films and
dried blood spots samples collected from 8,067 individuals enrolled in a nationwide, stratified, multistage, cluster sam-
pling malaria prevalence survey conducted in Cambodia in 2007. The overall malaria prevalence and prevalence rates of
Plasmodium falciparum, Plasmodium vivax, and Plasmodium malariae infections estimated by microscopy (N ¼ 8,067)
were 2.74% (95% confidence interval [CI]: 2.39–3.12%), 1.81% (95% CI: 1.53–2.13%), 1.14% (95% CI: 0.92–1.40%),
and 0.01% (95% CI: 0.003–0.07%), respectively. The overall malaria prevalence based on PCR detection (N ¼ 7,718)
was almost 2.5-fold higher (6.31%, 95% CI: 5.76–6.89%, P < 0.00001). This difference was significantly more pronounced
for P. falciparum (4.40%, 95% CI: 3.95–4.90%, P < 0.00001) compared with P. vivax (1.89%, 95% CI: 1.60–2.22%,
P < 0.001) and P. malariae infections (0.22%, 95% CI: 0.13–0.35%, P < 0.0001). The significant proportion of
microscopy-negative but PCR-positive individuals (289/7,491, 3.85%) suggest microscopic examination frequently
underestimated malaria infections and that active case detection based on microscopy may miss a significant reservoir
of infection, especially in low-transmission settings.
BACKGROUND
Over the past 15 years, Cambodia has made significant
strides in controlling malaria with the introduction of artemisinin-
based combinations, establishing rapid diagnosis tests (RDTs),
and treatment through a system of village malaria health
workers (set up in 2001 and scaled up in 2004) and the recent
wide distribution of long-lasting insecticide-treated bed nets
(LLITNs).1–4 In 2011, Cambodia committed itself to eliminat-
ing malaria by 2025. This goal may be challenged by the emer-
gence of multidrug-resistant, including artemisinin-resistant
Plasmodium falciparum (ART-R)5–8 and, now, the demise of
dihydroartemisinin–piperaquine.9
Accordingly, conducting accurate, large-scale assessments
of malaria prevalence, including pools of asymptomatic indi-
viduals detected by the polymerase chain reaction (PCR), is
crucial for planning malaria control and elimination efforts
and in measuring the impact of pertinent interventions. In
Cambodia, efforts are being focused on containing the spread
and ultimately the elimination of ART-R; thus, identifying
and quantifying reservoirs of falciparum infection are seen as
essential because these pools represent areas where there is
ongoing transmission of ART-R.
Conventionally, quantitative malariometric surveys are
mainly based on light microscopy (LM) diagnosis and, more
recently, RDTs, which are tools with limits of detection that
range from 50 to 200 malaria parasites/μL.10 In recent years,
various molecular detection approaches like PCR, with lower
theoretical limits of detection (0.5–5 parasites/μL), have been
increasingly used for improving the detection of malaria
infections. In malaria prevalence surveys, it has been shown
that PCR may detect twice as many cases as microscopy,11
and that most of the positive cases harbor asexual and sexual
parasites. Such asymptomatic cases are able to transmit infec-
tion to mosquitoes without coming to the attention of the
health system, and so may complicate malaria control.12–14
Although submicroscopic parasitemias may be less infective
to mosquitoes than microscopically detectable ones, they may
nonetheless be an important source of transmission because
they are severalfold more prevalent than microscopic para-
sitemias.15 These undetected reservoirs maintain parasite
populations, especially multidrug-resistant parasites, and may
contribute to the spread of ART-R within Cambodia through
the movement of migrant and mobile populations.
Although studies have compared the performances of PCR
and microscopy, few published studies have compared parasite
prevalence rates estimated by these two methods at the
national level.16,17 Nationwide malaria prevalence surveys
have been conducted in Cambodia in 2004, 2007, 2010, and
2013; PCR detection was first used in 2007. Herein, we report
the microscopy and PCR results of the 2007 national survey.
MATERIALS AND METHODS
Survey design and study population. The 2007 Cambodian
National Malaria Survey (CNMS) was a stratified, multistage
cluster sampling design study. The country was stratified into
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three domains (Figure 1) based on the malaria prevalence
results of the 2004 CNMS.18 Domain 1 consisted of the
northeastern provinces of Mondulkiri, Oddor Meanchey,
Preah Vihear, Rattanakiri, and Stung Treng and the southern
province of Koh Kong (high-transmission areas); Domain 2
consisted of the central and western provinces of Banteay
Meanchey, Battambang, Kampong Thom, Kratie, Pailin,
Pursat, and Siem Reap (low-transmission areas). The Domain
3 includes the remaining provinces around Phnom Penh (not
sampled here due to the very low malaria prevalence found in
the 2004 survey).
Each domain was further stratified into risk zones based
on the distance from the nearest forest margin. Risk zones 1,
2, 3, and 4 correspond to distances from the forest of 0–
250 m, 250–1,000 m, 1–2 km, and 2–5 km, respectively. Within
Domains 1 and 2, 38 clusters were randomly sampled: 14 from
risk zone 1 and eight from each of the other three risk zones.
Within each cluster, 40 households were randomly chosen
from the village census list maintained by the village leaders.
Within each household, a fingerprick blood sample was taken
from four individuals, one from each of the following groups:
one aged 0–4 years, one aged 5–14 years, one adult female,
and one adult male. If there was more than one person in any
of these groups, one was sampled randomly from all individ-
uals falling in that group. In addition, any pregnant woman in
the household who was not already sampled was included in
the blood sampling.
Random selection of clusters was not based on probability
proportional to size, and so was not self-weighting. Weights
were determined by census data collected at the time of
sampling, and took into account the probability of selection
of individual subjects based on both cluster size and the dis-
tribution of age categories in individual households.
All study subjects gave informed consent; the study was
approved by the National Ethics Committee for Health
Research of the Cambodian Ministry of Health (097 NECHR
dated October 26, 2007), and was conducted in compliance
with the international standards for the protection of
human research subjects, the participation of Naval Medical
Research Unit 2 was approved by the NAMRU-2 Institu-
tional Review Board.
Blood sampling. Fingerprick blood samples from 8,067
individuals enrolled in a large-scale malaria prevalence sur-
vey in Cambodia conducted in October–December 2007
at the end of the rainy season, including 3,363 households in
13 provinces in Domains 1 and 2, were collected and used
for microscopic examination of blood films and the detection
of DNA using a PCR assay based on the Plasmodium mito-
chondrial cytochrome b gene from blood spots. The national
malaria prevalence estimated both by microscopy and PCR
was investigated and compared along with the main determi-
nants associated with the malaria transmission in Cambodia.
Microscopic examination. Using blood from a fingerstick,
thick and thin films for malaria microscopy were prepared
by field workers in the households during the survey, and
were stained with Giemsa stain on the day of collection,
according to the WHO protocol.19 Blood films were exam-
ined by a certified microscopist using + 1,000 oil immersion
FIGURE 1. Malaria prevalence estimated by microscopy and distribution of the individual clusters, Cambodia, 2007. Domains 1 and 2 are
shown in dark and light gray, respectively. The color assigned to each cluster corresponds to the malaria prevalence (%) estimated by micros-
copy (all species). The number beside each colored cluster indicates the risk zone: risk zone 1 (0–250 m from forest), risk zone 2 (250–1,000 m),
risk zone 3 (1–2 km), and risk zone 4 (2–5 km).
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LM. At least, 200 ocular fields were reviewed before a slide
was considered negative. Parasites were counted per 200 leu-
kocytes and reported as parasites/μL, assuming a white blood
cell count of 8,000/μL. A second, senior certified microscopist
reviewed all positive smears and 10% of negative smears. In
the event of discrepancies, the senior microscopist’s reading
was recorded.
DNA extraction and PCR assay. From the same fingerprick,
2–3 drops of blood were blotted onto Whatman No. 3 filter
paper (Sigma-Aldrich, Singapore), dried at ambient tempera-
ture, and placed in ziplock bags with a desiccant. DNA extrac-
tion, detection of Plasmodium DNA by nested PCR, and
identification of the Plasmodium species (by sequencing the
PCR products) were carried out as previously described.20 In
brief, two sets of primers were used to amplify an 815–base
pair sequence of Plasmodium mitochondrial cytochrome b.
The species were determined by analysis of single nucleotide
polymorphisms at 11 sites within the PCR product.
Statistical analysis. All data were recorded on standardized
case report forms, double entered into MS Access (Microsoft
Inc., Redmond, WA), and exported for analysis to STATA
(version 10.0; StataCorp LP, College Station, TX). The data
were analyzed using survey analysis commands with eight
strata (two domains and four risk zones in each domain); the
primary sampling unit was the cluster, no finite population
correction was used, and sample weights were calculated as
the inverse of the probability of selecting each cluster. Line-
arized standard errors were calculated. Continuous data
were compared by the unpaired t test (log transforming data,
as needed), and proportional data were compared using the
χ2 test. All statistical tests were two-tailed, and significance
was defined as P < 0.05.
RESULTS AND DISCUSSION
In total, 8,067 individuals were sampled from 3,363 house-
holds in 137 clusters in 13 provinces (Figure 1). Households
numbered 2,110, 2,343, 1,820, and 1,794 from risk zones 1, 2,
3, and 4, respectively.
The male-to-female ratio was 0.89 and the median age was
23 years (95% confidence interval [CI]: 23–24 years). Of the
sampled population, 63% was ≥ 15 years of age, 22% aged
5–14 years, and 15% were children aged from 0 to 4 years.
Details of demographic data per domain and risk zone are
provided in Table 1.
A total of 7,707 blood samples were tested both by micros-
copy and PCR among the 8,067 individuals enrolled in the
national survey (95.4%). The distribution of the clusters
sampled and the malaria prevalence in each cluster, deter-
mined by microscopy, are shown in Figure 1. The study did
not sample enough sites in each province to produce reliable
prevalence estimates at the provincial level. However, high
prevalence clusters were mainly located in the northeastern
provinces, known to be the highest malaria transmission set-
tings in the country. As a consequence, the overall malaria
prevalence rates estimated both by microscopy and PCR
were significantly higher in high transmission areas: 4.5%
and 9.8%, respectively, in Domain 1 compared with 0.7%
and 2.2%, respectively, in Domain 2 (P < 0.0001).
Comparing the malaria prevalence rates between the risk
zones, the risk of being malaria positive decreased with
increasing distance from the forest margin, regardless of the
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domain and the method of detection. In Domain 1, malaria
prevalence by microscopic detection ranged from 6.2% in
risk zone 1 to 0.5% in risk zone 4 (χ2 test for trend, P <
0.001), and from 15.3% in risk zone 1 to 2.3% in risk zone 4
by PCR (χ2 test for trend, P < 0.001). In Domain 2, malaria
prevalence by microscopic detection ranged from 1.2% in
risk zone 1 to 0.5% in risk zone 4 (χ2 test for trend, P ¼
0.04), and from 3.8% in risk zone 1 to 1.4% in risk zone 4 by
PCR (χ2 test for trend, P < 0.01; Figure 2).
On the basis of microscopy or PCR, malaria prevalence
rates declined with increasing age in the high malaria trans-
mission areas of Domain 1 (Figure 3): 6.3% in 0–14 years
age group versus 3.5% in ≥ 15 years age group (microscopy,
P < 0.001) and 11.4% versus 8.8% (PCR, P < 0.01). These
data are consistent with other findings in Africa, where age
has been strongly associated with malaria infection (detected
by RDT or PCR), especially for children aged 0–10 years.21
However, in low-transmission settings of Domain 2, the
opposite trend was found for microscopy (0.2% in 0–14 years
age group versus 1.0% in ≥ 15 years age group, P < 0.01).
These data demonstrate how the malaria epidemiology can
vary according to the ecological environment, the distribu-
tion of the vectors species, and human behavior, especially in
unstable transmission areas.22–25 This trend may be explained
partly by the intense efforts at malaria control in Domain 2,
where prompt malaria treatment is achieved through the
widespread use of malaria RDTs and artemisinin-combined
therapies in health facilities and at community level coupled
with the increased coverage of LLITNs and indoor residual
spraying that have led to a substantial fall in malaria transmis-
sion. This may have led to a slowing of the development of
malaria immunity in adults who are still at a high risk of
contracting malaria because of their work in the forests.
The distribution of parasite densities across the age groups is
displayed in Figure 4. For individuals infected by P. falciparum
(Panel A), higher parasitemia was overrepresented in the 0–
14 years age group compared with ≥ 15 years age group, with
a nonsignificant difference between the geometric mean
values (1, 050 parasites/μL in the 0–14 years age group versus
410 parasites/μL in the ≥ 15 years age, P ¼ 0.1). Although not
significant, the trend of lower parasitemia with increasing age
in Domain 1 suggests the development of some clinical immu-
nity to malaria.26,27
By contrast, for individuals with vivax infections (Panel B),
the geometric mean parasitemia was 50-fold lower and
almost similar between age groups (84 parasites/μL in the
0–14 years age group versus 45 parasites/μL in the ≥ 15 years
age, P ¼ 0.9). Our parasitemia data are consistent with those
of Baird and others, who demonstrated that the development
of immunity to malaria was slower for P. vivax compared
with P. falciparum.28,29
Overall malaria prevalence rates in both domains com-
bined using microscopy or PCR are presented by species
in Figure 5. PCR-determined malaria prevalence rates were
FIGURE 2. Malaria prevalence by domain and risk zone, Cambodia,
2007. The malaria prevalences (any species) by domain and risk zone
as measured by microscopy and polymerase chain reaction (PCR) are
shown. Risk zones 1, 2, 3, and 4 correspond to distances from the
forest of 0–250 m, 250–1,000 m, 1–2 km, and 2–5 km.
FIGURE 3. Malaria prevalence by diagnostic methods (microscopy
and polymerase chain reaction [PCR]), Cambodia, 2007. The malaria
prevalence rates (any species) found by microscopic examination
and PCR detection are shown.
FIGURE 4. Distribution of microscopic parasitemias by age group,
Cambodia, 2007. The microscopic parasitemias by age group for
each domain are presented in Panel A for Plasmodium falciparum
infection and in Panel B for Plasmodium vivax infection.
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significantly higher for all malaria species compared with
microscopy: 1) for P. falciparum (4.40%, 95% CI: 3.95–
4.90% versus 1.6%, 95% CI: 1.4–2.0%, P < 0.00001), 2)
P. vivax (1.89%, 95% CI: 1.60–2.22% versus 1.1%, 95% CI:
0.9–1.4%, P < 0.001), and 3) P. malariae infections (0.22%,
95% CI: 0.13–0.35% versus 0.01%, 95% CI: 0.0003–0.07%,
P < 0.0001). Only one ovale infection was detected by
PCR (0.01%) and missed by microscopy. The proportions of
P. falciparum/P. vivax mixed infections detected by micros-
copy and PCR were not significantly different (0.20%, 95%
CI: 0.12–0.32% versus 0.20%, 95% CI: 0.12–0.35%, P ¼ 1).
Among the samples tested as negative by microscopy, 3.85%
(289/7,491) were found positive by PCR. This included
186 P. falciparum, 75 P. vivax, 16 P. malariae, 11 mixed
P. falciparum/P. vivax and one Plasmodium ovale infections.
Our findings demonstrate that large reservoirs of sub-
microscopic infections are common in Cambodia, and are
approximately two to three times more common compared
with microscopy and represent a significant source of trans-
mission.30 It is worth noting that an elimination strategy
based on microscopic mass screening and treatment would
miss the majority of infected individuals, confirming our pre-
vious observations in Pailin Province.31 Similarly, at the vil-
lage level, more than a third of villages which appear free of
malaria based on microscopy alone actually harbor infection.
Factors associated with submicroscopic P. falciparum and
P. vivax infections were individuals living in high-transmission
settings (Domain 1: 3.9% versus Domain 2: 0.9%, P <
0.0001 for P. falciparum and Domain 1: 1.6% versus Domain
2: 0.6%, P < 0.0001 for P. vivax), and living close to forested
areas (risk zones 1 and 2: 3.0% and 3.8% versus risk zones 3
and 4: 2.2% and 0.8% for P. falciparum, P < 0.0001 and risk
zones 1, 2, and 3: 1.1%, 1.7%, and 1.2% versus risk zone 4:
0.4% for P. vivax, P < 0.01). Strategies to protect high-risk
individuals from contracting malaria need to be developed,
taking into account that the two main forest-related vectors,
Anopheles dirus and Anopheles minumus are outdoor biting
mosquitoes.22,32
Surprisingly, the PCR failed to detect 18 infections
(0.23%) found positive by microscopy (five P. falciparum, 12
P. vivax, and one mixed P. falciparum/P. vivax). All samples
missed by PCR had a parasite density < 100 parasites/μL,
except for two P. falciparum (20,000 and 3,560 parasites/μL)
and one P. vivax infections (3,880 parasites/μL), representing
clear PCR false-negative results probably due to technical
errors (presence of PCR inhibitors for instance). Finally, there
were 29/7,707 (0.38%) cases in which microscopy and PCR
gave different species identifications: half cases (15 cases)
involved cases that were reported as mixed P. falciparum/
P. vivax infections by microscopy but were classified as mono-
infections by PCR (14 P. falciparum and one P. vivax; Table 2).
The data presented in this study are reliable baseline esti-
mates from which to assess the trends in malaria prevalence
rates with successive national malaria surveys. Our findings
reinforce previous observations11,33 in which the prevalence
of infection measured by PCR was, on average, twice that
measured by microscopy. The recent shift from control to
elimination with elimination as the ultimate goal will require
a rigorous assessment of reservoirs of infection, including sub-
microscopic infections. Cambodia has committed itself to the
elimination of malaria by 2025. To reach this goal, asymptom-
atic reservoirs should be detected to assess the true prevalence
FIGURE 5. Malaria prevalence by species. The estimated preva-
lences for the entire surveyed area for any Plasmodium species
(Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae,
Plasmodium ovale, and mixed P. falciparum/P. vivax), as measured
by microscopy and polymerase chain reaction (PCR) are shown.
TABLE 2
Comparison of microscopy and PCR for the detection of asymptomatic malaria in 7,707 samples collected in endemic area in Cambodia in 2007
PCR ¼ polymerase chain reaction; P. falciparum ¼ Plasmodium falciparum; P. malariae ¼ Plasmodium malariae; P. ovale ¼ Plasmodium ovale; P. vivax ¼ Plasmodium vivax.PCR ¼ polymerase chain reaction; P. falciparum ¼ Plasmodium falciparum; P. malari e ¼ Plasmodium alari e; P. ovale ¼ Plasmodium ovale; P. vivax ¼ Plasmodium vivax.
In the table, green cells indicate concordant results between microscopy and PCR (95.6%); yellow cells indicate microscopy-positive/PCR-negative results (0.2%); orange cells indicate microscopy-
negative/PCR-positive results; and black cells (3.7%) indicate discordant results for Plasmodium identification (0.4%).
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of parasitemia to design an evidence-based elimination strat-
egy and put in place a comprehensive surveillance system to
assess the impact of the implemented strategies. Control
methods based either on mass screening and treatment or
targeted mass drug administration will only be effective if the
screening method identifies submicroscopic reservoirs of infec-
tion. Cambodia may, therefore, need to shift its current
emphasis on parasitological diagnosis based on RDTs and
microscopy to high-throughput PCR with rapid communica-
tion to the field to find and eliminate hidden parasite reser-
voirs in transmission foci or to new molecular technologies
implementable in the field, such as loop mediated isothermal
amplification34 or capture and ligation probe-polymerase chain
reaction.35 In addition, seroprevalence surveys of P. falciparum
may complement current diagnostic tools and provide useful
insight into malaria exposure levels and an estimation of the
transmission intensity.36 Lastly, to improve the malaria surveil-
lance and monitoring, more data are needed to assess the role
of submicroscopic infections in maintaining the transmission
cycle through the low-transmission dry season.
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